期刊文献+

骨形态发生蛋白9抑制人乳腺癌MDA-MB-231细胞体外侵袭和迁移 被引量:9

BMP9 inhibits invasion and migration of human MDA-MB-231 cells in vitro
下载PDF
导出
摘要 目的探讨骨形态发生蛋白9(BMP9)对乳腺癌MDA-MB-231细胞侵袭、迁移能力的影响。方法 RT-PCR法检测MDA-MB-231细胞系中BMP9的表达;扩增高滴度的BMP9表达腺病毒,感染MDA-MB-231细胞,制备高表达BMP9的重组MDA-MB-231/BMP9细胞,以此作为实验组;同时以含GFP的空载腺病毒感染该细胞为MDA-MB-231/GFP,联合空白MDA-MB-231共同作为对照组;通过平板集落形成实验、细胞划痕实验、Transwell侵袭实验检测重组MDA-MB-231/BMP9细胞侵袭及迁移能力。结果与对照组细胞相比,实验组细胞中BMP9 mRNA表达水平明显增高;实验组细胞集落形成率由对照的90.6%±2.5%与85.6%±3.5%显著下降至57.3%±4.5%(P<0.05);实验组划痕愈合率由对照的95.4%±3.1%与92.5%±2.4%下降至74.0%±3.6%(P<0.05);实验组穿膜细胞数由对照的(255.3±16.1)个与(267.3±14.9)个下降至(150.3±14.6)个(P<0.05)。结论 BMP9可以在体外抑制乳腺癌MDA-MB-231细胞的侵袭与迁移。 Objective To investigate the correlation among bone morphogenetic protein 9(BMP9) expression,migration and invasion of breast cancer MDA-MB-231 cells in vitro.Methods The expression of BMP9 in MDA-MB-231 was detected by RT-PCR,high titer of adenovirus vector expressing BMP9 was used to infect MDA-MB-231.Experimental group: MDA-MB-231/BMP9,control group: MDA-MB-231/GFP and MDA-MB-231.To detect the changes of invasion and migration in the recombinant MDA-MB-231/BMP9 cells colony-forming assay,cell wounding assay,Transwell invasion assay were carried out.Results Compared with MDA-MB-231/GFP cells and MDA-MB-231 cells,the mRNA level of BMP9 was increased in MDA-MB-231/BMP9 cells.The cell colony formation rate of experimental group was decreased.The healing rate of experimental group was lower than that of control group.The number of invading cells which moved across the matrix barrier for experimental group was less that than that of control group.Conclusion BMP9 can inhibit the invasion and migration of breast cancer in vitro.
出处 《基础医学与临床》 CSCD 北大核心 2011年第4期360-365,共6页 Basic and Clinical Medicine
基金 国家自然科学基金(30800658)
关键词 骨形态发生蛋白9 乳腺癌 肿瘤侵袭 BMP9 breast cancer tumor invasion
  • 相关文献

参考文献12

  • 1Alarmo EL, Kallioniemi A. Bone morphogenetic proteins in breast cancer:dual role in tumourigenesis [ J ]. Endocr Relat Cancer, 2010, 17 : 123 - 139.
  • 2Alarmo EL, Korhonen T, Kuukasjarvi T, et al. Bone mor- phogenetic protein 7 expression associates with bone metas- tasis in breast carcinomas [ J~. Ann Oncol, 2008, 19:308-314.
  • 3Davies SR, Watkins G, Douglas-Jones A, et al. Bone mor- phogenetic proteins 1 to 7 in human breast cancer, expres- sion pattern and clinical/prognostic relevance [ J ]. J Exp Ther Oncol, 2008, 7:327-338.
  • 4Buijs JT, Que I, l~wik CW, et al. Inhibition of bone re-sorption and growth of breast cancer in the bone microenvi- ronment [J]. Bone, 2009, 44:380-386.
  • 5Alarmo EL, P~irssinen J, Ketolainen JM, et aL BMP7 in- fluences proliferation, migration, and invasion of breast cancer cells [J]. Cancer Lett, 2009, 275:35-43.
  • 6Herrera B, van Dinther M, Ten Dijke P, et al. Autocrine bone morphogenetie protein-9 signals through activin recep- tor-like kinase-2/Smadl/Smad4 to promote ovarian cancel cell proliferation [ J ]. Cancer Res, 2009, 69 : 9254 - 9262.
  • 7Ye L, Kynaston H, Jiang WG. Bone morphogenetic pro- tein-9 (BMP-9) induces apoptosis in prostate cancer ceils, the role of prostate apoptosis response-4 ( PAR-4 ) [ J ]. Mol Cancer Res. 2008.6 : 1594 - 1606.
  • 8David L, Mallet C, Keramidas M, et al. Bone morphoge- netic protein-9 is a circulating vascular quiescence factor [J]. Circ Res, 2008, 2:914 -922.
  • 9Scharpfenecker M, van Dinther M, Liu Z, et al. BMP-9 signals via ALK1 and inhibits bFGF-induced endoth~t'ial cell proliferation and VEGF-stimulated angiogenesis [ J]. J Cell Sci, 2007, 20:964-972.
  • 10Cunha SI, Pardali E, Thorikay M, et al. Genetic and pharmacological targeting of activin receptor-like kinase 1 impairs tumor growth and angiogenesis [ J ]. J Exp Med, 2010, 207:85 - 100.

同被引文献81

  • 1吴庆莲,舒畅.MMP-2、MMP-9含量表达与喉癌侵袭转移的相关性[J].中国老年学杂志,2014,34(11):2930-2932. 被引量:4
  • 2蒯建科,姚立农,于代华,张凤林,彭德民,杨永慧,柴伟.异氟醚对新生大鼠认知功能的影响[J].中华麻醉学杂志,2006,26(8):717-719. 被引量:12
  • 3Boér K.Current trends in pharmacotherapy of breast cancer.OrvHetil,2002,143(14):725-730.
  • 4Reddi A H.Bone and cartilage differentiation.Curr Opin GenetDev,1994,4(5):737-744.
  • 5Senta H,Park H,Bergeron E,et al.Cell responses to bonemorphogenetic proteins and peptides derived from them:biomedical applications and limitations.Cytokine Growth FactorRev,2009,20(3):213-222.
  • 6Herrera B,van Dinther M,Ten Dijke P,et al.Autocrine bonemorphogenetic protein-9 signals through activin receptor-likekinase-2/Smad1/Smad4 to promote ovarian cancer cellproliferation.Cancer Res,2009,69(24):9254-9262.
  • 7Ye L,Kynaston H,Jiang W G.Bone morphogenetic protein-9(BMP-9)induces apoptosis in prostate cancer cells,the role ofprostate apoptosis response-4(PAR-4).Mol Cancer Res,2008,6(10):1594-1606.
  • 8Alarmo E L,Rauta J,Kauraniemi P,et al.Bone morphogeneticprotein 7 is widely overexpressed in primary breast cancer.GenesChromosomes and Cancer,2006,45(4):411-419.
  • 9Constam D B,Robertson E J.Regulation of bone morphogeneticprotein activity by pro domains and proprotein convertases.J CellBiol,1999,144(1):139-149.
  • 10Zhu W,Kim J,Cheng C,et al.Noggin regulation of bonemorphogenetic protein(BMP)2/7 heterodimer activity in vitro.Bone,2006,39(1):61-71.

引证文献9

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部